Sodium Carbonate → 3-([1-(Tert-butoxycarbonyl)piperidin-4-ylidene]{4-[(diethylamino)carbonyl]phenyl}methyl)benzoic acid

HRID 1271675ノート

反応式

HRID 1271675 の反応式
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][C:11](=[C:14](Br)[C:15]2[CH:20]=[CH:19][C:18]([C:21](=[O:27])[N:22]([CH2:25][CH3:26])[CH2:23][CH3:24])=[CH:17][CH:16]=2)[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].[C:29]([C:32]1[CH:33]=[C:34](B(O)O)[CH:35]=[CH:36][CH:37]=1)([OH:31])=[O:30].C([O-])([O-])=O.[Na+].[Na+]>C1(C)C=CC=CC=1.C(O)C.[Pd].C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1>[CH2:23]([N:22]([CH2:25][CH3:26])[C:21](=[O:27])[C:18]1[CH:19]=[CH:20][C:15]([C:14](=[C:11]2[CH2:12][CH2:13][N:8]([C:6]([O:5][C:1]([CH3:4])([CH3:3])[CH3:2])=[O:7])[CH2:9][CH2:10]2)[C:36]2[CH:35]=[CH:34][CH:33]=[C:32]([C:29]([OH:31])=[O:30])[CH:37]=2)=[CH:16][CH:17]=1)[CH3:24]

参加物

7

反応物 3

HCID 10340Sodium CarbonateHCID 27339573-Carboxyphenylboronic acidHCID 10503756HCID 10503756、化合物

生成物 1

HCID 184529743-([1-(Tert-butoxycarbonyl)piperidin-4-ylidene]{4-[(diethylamino)carbonyl]phenyl}methyl)benzoic acid収率 70%

試薬・触媒・溶媒 3

HCID 11979704Tetrakis(triphenylphosphine)palladium触媒HCID 702Ethanol溶媒HCID 1140Toluene溶媒

反応条件

温度
90 °C

実験手順

A mixture of 4-[bromo-(4-diethylcarbamoyl-phenyl)-methylene]-piperidine-1-carboxylic acid tert-butyl ester (1a, 451 mg, 1.0 mmol), 3-carboxyphenyl boronic acid (330 mg, 2.0 mmol), 2M Na2CO3 (3 mL), and tetrakis(triphenyl phosphine) palladium(0) (25 mg) in toluene (degassed, 10 mL) and ethanol (degassed, 10 mL) was refluxed at 90° C. for 4 hrs under N2. The reaction mixture was then quenched with aqueous NH4Cl after cooling down to 0° C., and extracted with ethyl acetate (2×50 mL). The combined organic phases were washed with brine, dried over MgSO4, and evaporated to give a crude product, which was purified by flash silica gel column to provide the desired compound 2a (345 mg, 70%): 1H NMR (CDCl3) δ 1.15 (3 H, br m, CH3CH2—), 1.23 (3 H, br m, CH3CH2—), 1.47 (9 H, s, C(CH3)3), 2.31 (2 H, m, piperidine CH—), 2.35 (2 H, m, piperidine CH—), 3.30 (2 H, br m, CH3CH2N—), 3.48 (4 H, m, piperidine CH—), 3.54 (2 H, br m, CH3CH2N—), 7.14 (2 H, d, J=8.0 Hz, ArH), 7.24 (1 H, m, ArH), 7.33 (2 H, d, J=8.0 Hz, ArH), 7.42 (1 H, t, J=7.6 Hz, ArH), 7.86(1 H, s, ArH), 7.97 (1 H, d, J=7.6 Hz, ArH). IR (NaCl)2976, 1718, 1691, 1598, 1430, 1233, 1166 cm−1.

後処理

  1. customThe reaction mixture was then quenched with aqueous NH4Cl
  2. temperatureafter cooling down to 0° C.
  3. extractionextracted with ethyl acetate (2×50 mL)
  4. washThe combined organic phases were washed with brine
  5. dry with materialdried over MgSO4
  6. customevaporated
  7. customto give a crude product, which
  8. customwas purified by flash silica gel column

出典と根拠

ORDレコード
ord-44885e574756455cb0d3f58c8873b540
出典データセット
uspto-grants-2007_04
特許番号
US07205317B2

反応ノート

読み込み中…